National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting, 55849 [E9-25848]

Download as PDF Federal Register / Vol. 74, No. 208 / Thursday, October 29, 2009 / Notices Dated: October 23, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–26125 Filed 10–28–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 17, 2009, 8 a.m. to November 18, 2009, 5 p.m., William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854 which was published in the Federal Register on October 22, 2009, 74 FR 54585–54586. The meeting will be one day only November 17, 2009, from 8:30 a.m. to 8 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: October 23, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–26124 Filed 10–28–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health dcolon on DSK2BSOYB1PROD with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on November 10, 2009, from 8:30 a.m. to 3 p.m. at the Bethesda Hyatt Regency Hotel, 7400 Wisconsin Avenue, Bethesda, MD. The meeting will be open to the public, with attendance limited to space available. Non-Federal individuals planning to attend the meeting should notify the Contact Person listed on this notice at least 2 days prior to the meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below at least 10 days in advance of the meeting. VerDate Nov<24>2008 15:20 Oct 28, 2009 Jkt 220001 The DMICC facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The November 10, 2009, DMICC meeting will discuss ‘‘Diabetes Prevention: A National Priority.’’ Any member of the public interested in presenting oral comments to the Committee should notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present oral comments and presentations will be limited to a maximum of five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first come, first serve basis. A registration link and information about the DMICC meeting will be available on the DMICC Web site: https://www.diabetescommittee.gov. Members of the public who would like to receive e-mail notification about future DMICC meetings could register on a listserv available on the same Web site. For further information concerning this meeting contact Dr. Sanford Garfield, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460, Bethesda, MD 20892–5460, Telephone: 301- 594–8803 FAX: 301- 402–6271, email: dmicc@mail.nih.gov. Dated: October 19, 2009. Sanford Garfield, Executive Secretary, DMICC, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, National Institutes of Health. [FR Doc. E9–25848 Filed 10–28–09; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 55849 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Review of T32 Applications. Date: November 23, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call) Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892–9304, (301) 435–6680, skandasa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 23, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–26128 Filed 10–28–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5281–N–82] Public Housing Operating SubsidyStop-Loss and Appeals AGENCY: Office of the Chief Information Officer, HUD. E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 74, Number 208 (Thursday, October 29, 2009)]
[Notices]
[Page 55849]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25848]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting

    The Diabetes Mellitus Interagency Coordinating Committee (DMICC) 
will hold a meeting on November 10, 2009, from 8:30 a.m. to 3 p.m. at 
the Bethesda Hyatt Regency Hotel, 7400 Wisconsin Avenue, Bethesda, MD. 
The meeting will be open to the public, with attendance limited to 
space available. Non-Federal individuals planning to attend the meeting 
should notify the Contact Person listed on this notice at least 2 days 
prior to the meeting. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the Contact Person listed below at least 
10 days in advance of the meeting.
    The DMICC facilitates cooperation, communication, and collaboration 
on diabetes among government entities. DMICC meetings, held several 
times a year, provide an opportunity for members to learn about and 
discuss current and future diabetes programs in DMICC member 
organizations and to identify opportunities for collaboration. The 
November 10, 2009, DMICC meeting will discuss ``Diabetes Prevention: A 
National Priority.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present oral 
comments and presentations will be limited to a maximum of five 
minutes. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
with the Committee by forwarding their statement to the Contact Person 
listed on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Because of time constraints for 
the meeting, oral comments will be allowed on a first come, first serve 
basis.
    A registration link and information about the DMICC meeting will be 
available on the DMICC Web site: https://www.diabetescommittee.gov. 
Members of the public who would like to receive e-mail notification 
about future DMICC meetings could register on a listserv available on 
the same Web site.
    For further information concerning this meeting contact Dr. Sanford 
Garfield, Executive Secretary of the Diabetes Mellitus Interagency 
Coordinating Committee, National Institute of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460, 
Bethesda, MD 20892-5460, Telephone: 301- 594-8803 FAX: 301- 402-6271, 
e-mail: dmicc@mail.nih.gov.

    Dated: October 19, 2009.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. E9-25848 Filed 10-28-09; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.